458 related articles for article (PubMed ID: 11653321)
21. Changing federal regulation of IRB's: the Commission's recommendations and the FDA's proposals.
Levine RJ
IRB; 1979 Mar; 1(1):1-3+. PubMed ID: 11662736
[No Abstract] [Full Text] [Related]
22. Informed consent process and document is criticized in court.
Maloney DM
Hum Res Rep; 1994 Dec; 9(12):4-5. PubMed ID: 11654162
[No Abstract] [Full Text] [Related]
23. An IRB member's perspective on access to innovative therapy.
Moore DL
Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
[No Abstract] [Full Text] [Related]
24. Gene therapy in mental retardation: ethical considerations.
Fletcher JC
Ment Retard Dev Disabil Res Rev; 1995; 1():7-13. PubMed ID: 11660293
[No Abstract] [Full Text] [Related]
25. Proposed regulations for research involving those institutionalized as mentally infirm: a consideration of their relevance in 1995.
Levine RJ
Account Res; 1996; 4(3-4):177-86. PubMed ID: 11654513
[No Abstract] [Full Text] [Related]
26. Demarcating research and treatment interventions: a case illustration.
Goldberg JL; Phillips JO; Freedman B; Weijer C
IRB; 1992; 14(4):5-8. PubMed ID: 11651393
[No Abstract] [Full Text] [Related]
27. Proposed requirements for informed consent go beyond current federal regulations.
Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879
[No Abstract] [Full Text] [Related]
28. Considering behavioral and biomedical research on detainees in the mental health unit of an urban mega-jail.
Brakel SJ
N Engl J Crim Civ Confin; 1996; 22(1):1-27. PubMed ID: 11660427
[No Abstract] [Full Text] [Related]
29. FDA revises informed consent regulations for emergency research.
Menasché A; Levine RJ
IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
[No Abstract] [Full Text] [Related]
30. IRBs and pharmaceutical company funding of research.
Jellinek MS; Levine RJ
IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
[No Abstract] [Full Text] [Related]
31. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
32. Non-therapeutic medical research involving human subjects.
Bloom MJ
Syracuse Law Rev; 1973; 24():1067-1099. PubMed ID: 11664224
[No Abstract] [Full Text] [Related]
33. Reviewing subject recruitment: new rules from Rockville.
McMahon FG
IRB; 1988; 10(3):6-7. PubMed ID: 11651911
[No Abstract] [Full Text] [Related]
34. Regulation of research on the decisionally impaired: history and gaps in the current regulatory system.
Moreno JD
J Health Care Law Policy; 1998; 1(1):1-21. PubMed ID: 15573427
[No Abstract] [Full Text] [Related]
35. Consent to research with impaired human subjects: a trial policy for the intramural programs of the National Institutes of Health.
Fletcher JC; Dommel FW; Cowell DD
IRB; 1985; 7(6):1-6. PubMed ID: 11649686
[No Abstract] [Full Text] [Related]
36. Issues related to the protection of human research participants.
Harrison L
J Neurosurg Nurs; 1993 Jun; 25(3):187-93. PubMed ID: 11660053
[No Abstract] [Full Text] [Related]
37. Psychiatric guinea pigs are left in limbo.
Boyce N
New Sci; 1998 Nov; 160(2162):21. PubMed ID: 11660595
[No Abstract] [Full Text] [Related]
38. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
Kobasic DM
J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
[No Abstract] [Full Text] [Related]
39. Informed consent to human subject research: improving the process of obtaining informed consent from mentally ill persons.
Derrickson D
Fordham Urban Law J; 1997; 25(1):143-65. PubMed ID: 12173638
[No Abstract] [Full Text] [Related]
40. The FDA's final regulations: IRBs and medical devices.
Holder AR
IRB; 1980; 2(6):1-4. PubMed ID: 11661803
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
